RxDoctor Payments Data

Zachary Curtis, MD

Interventional Cardiology · Morgantown, WVNPI 1336674290

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (36.4%), food and beverage and grants — rather than concentrated in one kind of arrangement. 22 manufacturers reported payments, led by Medtronic at 24.1% of the total. Reporting peaked in 2024 at $9,667 and has fallen 83.3% since, to $1,612 in 2025.

$13,613in general payments, 2019–2025

Across 146 payments — averaging $93.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$3K
  • Terumo Medical Corporation$3K
  • Abbott$2K
  • Inari Medical, Inc.$1K
  • Boston Scientific$1K
  • Penumbra, Inc.$638
  • plus $3K from 16 others

What the payments were for

  • Grants$4,06330%
  • Travel & lodging$4,95836%
  • Food & beverage$4,43033%
  • Education$1611%

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$13,613 in reported general payments places this provider in the 75th percentile of 46 interventional cardiology providers in West Virginia.

See all interventional cardiology providers in West Virginia

Medicare billing

Part B allowed, 2024
$31,132
Medicare patients
219
Services billed
417

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
ClopidogrelClopidogrel Bisulfate25$250
Atorvastatin Calcium11$125

Paid to pharmacies, not to this prescriber.

Other interventional cardiology in Morgantown

See the full list for West Virginia

Where these figures come from

Is this you, or does something look wrong? →